Skip NavigationSkip to Content

Aberrant Clonal Hematopoiesis following Lentiviral Vector Transduction of HSPCs in a Rhesus Macaque

  1. Author:
    Espinoza, Diego A
    Fan, Xing
    Yang, Di
    Cordes, Stefan F
    Truitt, Lauren L
    Calvo, Katherine R
    Yabe, Idalia M
    Demirci, Selami
    Hope, Kristin J
    Hong, So Gun
    Krouse, Allen
    Metzger, Mark
    Bonifacino, Aylin
    Lu, Rong
    Uchida, Naoya
    Tisdale, John F
    Wu,Xiaolin
    DeRavin, Suk See
    Malech, Harry L
    Donahue, Robert E
    Wu, Chuanfeng
    Dunbar, Cynthia E
  2. Author Address

    Translational Stem Cell Biology Branch, National Heart, Lung, and Blood Institute, NIH, Bethesda, MD 20892, USA; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Translational Stem Cell Biology Branch, National Heart, Lung, and Blood Institute, NIH, Bethesda, MD 20892, USA., Translational Stem Cell Biology Branch, National Heart, Lung, and Blood Institute, NIH, Bethesda, MD 20892, USA; Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China., Sickle Cell and Vascular Biology Branch, National Heart, Lung, and Blood Institute, NIH, Bethesda, MD, USA., Stem Cell and Cancer Research Institute, McMaster University, Hamilton, ON, Canada., Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research, University of Southern California, Los Angeles, CA, USA., Cancer Research Technology Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD, USA., Translational Stem Cell Biology Branch, National Heart, Lung, and Blood Institute, NIH, Bethesda, MD 20892, USA. Electronic address: wuc3@mail.nih.gov., Translational Stem Cell Biology Branch, National Heart, Lung, and Blood Institute, NIH, Bethesda, MD 20892, USA. Electronic address: dunbarc@nhlbi.nih.gov.,
    1. Year: 2019
    2. Date: Jun 5
    3. Epub Date: 2019 04 09
  1. Journal: Molecular therapy : the journal of the American Society of Gene Therapy
    1. 27
    2. 6
    3. Pages: 1074-1086
  2. Type of Article: Article
  3. ISSN: 1525-0016
  1. Abstract:

    Lentiviral vectors (LVs) are used for delivery of genes into hematopoietic stem and progenitor cells (HSPCs) in clinical trials worldwide. LVs, in contrast to retroviral vectors, are not associated with insertion site-associated malignant clonal expansions and, thus, are considered safer. Here, however, we present a case of markedly abnormal dysplastic clonal hematopoiesis affecting the erythroid, myeloid, and megakaryocytic lineages in a rhesus macaque transplanted with HSPCs that were transduced with a LV containing a strong retroviral murine stem cell virus (MSCV) constitutive promoter-enhancer in the LTR. Nine insertions were mapped in the abnormal clone, resulting in overexpression and aberrant splicing of several genes of interest, including the cytokine stem cell factor and the transcription factor PLAG1. This case represents the first clear link between lentiviral insertion-induced clonal expansion and a clinically abnormal transformed phenotype following transduction of normal primate or human HSPCs, which is concerning, and suggests that strong constitutive promoters should not be included in LVs. Published by Elsevier Inc.

    See More

External Sources

  1. DOI: 10.1016/j.ymthe.2019.04.003
  2. PMID: 31023523
  3. PMCID: PMC6554657
  4. WOS: 000470107900003
  5. PII : S1525-0016(19)30167-4

Library Notes

  1. Fiscal Year: FY2018-2019
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel